Double-blind study of atorvastatin versus placebo to reduce cardiopulmonary complications after thoracic surgery.
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2015
At a glance
- Drugs Atorvastatin (Primary)
- Indications Acute coronary syndromes; Atrial fibrillation
- Focus Therapeutic Use
- 29 May 2014 Trial status changed from active, no longer recruiting to completed as reported by clinicaltrials.gov.
- 30 Jan 2014 Planned End Date changed from 1 Jul 2013 to 1 Jul 2014, according to ClinicalTrials.gov record.
- 07 Jan 2013 Planned end date changed from 1 Jul 2012 to 1 Jul 2013 as reported by clinicaltrials.gov.